Additionally, ESCC biomarkers identified in previous study, such as ACTA2, ANXA1 [25], HSPA9, THBS1 [26] etc. were also detected in EESCC, indicating the key events in advanced-stage cancer happened as earlier as in the early-stage cancer. This evidence concerns the gene ACTA2 and esophageal squamous cell carcinoma.